Area of research
Neurology · Molecular Biology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Pluripotent Stem Cells Research, Neuroinflammation and Neurodegeneration Mechanisms, and Alzheimer's disease research and treatments.
SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson’s disease in human dopaminergic neurons and a mouse model
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease
GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers
α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
Tauroursodeoxycholic Acid Protects against the Effects of P-Cresol-Induced Reactive Oxygen Species via the Expression of Cellular Prion Protein
PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival
Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis
Melatonin Rescues Mesenchymal Stem Cells from Senescence Induced by the Uremic Toxin <i>p</i>-Cresol via Inhibiting mTOR-Dependent Autophagy
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Tauroursodeoxycholic acid reduces ER stress by regulating of Akt-dependent cellular prion protein